program Spolupráce (Cooperation)

- celkem 69 projektů: z toho MFF (15); COŽP (10); 1.LF, PřF (9); 2.LF (7); 3.LF (4); FF, FSV (3); LF HK, LF Plzeň (2); PedF, FHS, PF, CTS, FaF (1)

1. Increasing the participation of the elderly in clinical trials (PREDICT); HEALTH-2007-2.2.2-4; 01/02/2008 - 31/07/2010; CSA; Prof. MUDr. Eva Topinková, DrSc.; 1.LF

2. Services and Health for Elderly in Long TERm care (SHELTER); FP7-HEALTH-2007-B; 01/01/2009 - 31/12/2011; CP; Prof. MUDr. Eva Topinková, DrSc.; 1.LF

3. Promotion and facilitation of international cooperation with Eastern European and Central Asian Countries (EECAlink); FP7-HEALTH-2007-B; 01/06/2009 - 30/11/2011; CSA; prof. MUDr. Stanislav Štípek, DrSc. - Coordinator; 1.LF

4. Efficacy and safety of inhaled budesonide in very preterm infants at risk for bronchopulmonary dysplasia (NEUROSIS); HEALTH-2007-4.2-1; 01/03/2009 - 28/02/2014; CP; Prof. MUDr. Richard Plavka, CSc.; 1.LF

5. Cancer Genomics of the Kidney (CAGEKIG); FP7-HEALTH-2009-two-stage; 01/03/2010 - 28/02/2014; CP; MUDr. Ivana Holcátová, CSc.; 1.LF

6. Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD); FP7-HEALTH-2011-single-stage; 01/10/2011 - 30/09/2014; CP; Prof. MUDr. Martin Haluzík, DrSc.; 1. LF

7. A Randomized Clinical Trial to Evaluate the Effectiveness of a Multi-Modal Intervention in Older People (MID-FRAIL-STUDY); FP7-HEALTH-2011-two-stage; CP; 01/03/2012 - 29/02/2016; Prof. MUDr. Eva Topinková; 1.LF

8. Epigenetics for female personalized cancer care (EPI-FEM-CARE); 01/11/2012 - 30/04/2016; FP7-HEALTH-2012-INNOVATION-1;Prof. MUDr. David Cibula; CSc. 1.LF

9. A European platform of integrated information services for researchers in the field of rare diseases and orphan drugs supporting team and project building (RareDiseasePlatform); HEALTH-2007-2.4.4-2; 01/05/2008 - 30/04/2011; CSA; Prof. MUDr. Milan Macek, DrSc.;


10. Controlling chronic diseases related to metabolic disorders (METABO); ICT-2007.5.1; 01/01/2008 - 30/06/2011; CP; MUDr. ing. Jan Vejvalka; 2.LF

11. Improving diagnoses of mental retardation in children in Central Eastern Europe and Central Asia through genetic characterisation and bioinformatics/statistics (CHERISH); HEALTH-2007-2.2.1-10; 01/02/2009 - 31/07/2012; CP; Prof. Ing. Zdeněk Sedláček, CSc.;


12. Technological innovation of high throughput molecular diagnostics of clinically and molecularly heterogeneous genetic disorders (TECHGENE); FP7-HEALTH-2007-B; 01/02/2009 - 31/01/2012; CP; MUDr. Milan Macek, Jr., DrSc.; 2.LF

13. European networks of centres of expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation); (ENCE-CF-LAM-LTX); FP7-HEALTH-2007-B; 01/04/2009 - 31/03/2011; CSA; MUDr. Milan Macek, Jr., DrSc.; 2.LF

14. Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services (EuroGentest2); FP7-HEALTH-2010-single-stage; 01/01/2011 - 31/12/2013; CSA; MUDr. Milan Macek, Jr., DrSc.; 2.LF

15. RD-Connect: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research (RD-Connect); FP7-HEALTH-2012-INNOVATION-1; 01/11/2012 - 31/10/2018; MUDr. Milan Macek, Jr., DrSc.; 2.LF

16. Adipokines as drug targets to combat adverse effects of excess adipose tissue (ADAPT); HEALTH-2007-2.4.3-4; 01/02/2008 - 31/01/2012; CP; Doc. MUDr. Vladimír Štich, Ph.D; 3.LF

17. Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn (The HIP Trial); FP7-HEALTH-2010-single-stage; 01/10/2010 - 30/09/2015; CP; Doc. MUDr. Zbyněk Straňák, CSc.; 3.LF

18. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention of early diabetic nephRopathy (PRIORITY); FP7-HEALTH-2011-two-stage; 01/01/2012 - 31/12/2017; CP; Prof. Ivan Rychlík; 3.LF

19. Health Care Reform: the iMpact on practice, oUtcomes and costs of New roles for health Professional; (MUNROS); FP7-HEALTH-2012-INNOVATION-1; 01/10/2012 - 30/09/2016; Mgr. Hana Svobodová; 3.LF

20. European network for genetic-epidemiological studies: building a method to dissect complex genetic traits, using essential hypertension as a disease model (HYPERGENES); HEALTH-2007-2.1.1-2; 01/01/2008 - 31/12/2011; CP; Doc.MUDr. Jan Filipovský, CSc.; LF Plzeň

21. Fighting aneurysmal diseases (FAD); HEALTH -2007-2.4.2-2; 01/07/2008 - 30/06/2012; CP; Prof.MUDr. Vladislav Třeška, DrSc.; LF Plzeň

22. Utilisation of the mesenchymal stem cell receptome for rational development of uniform, serum-free culture conditions and tools for cell characterization (PURSTEM); HEALTH-2007-1.4-7; 01/11/2008 - 30/4/2012; CP; MUDr. Tomáš Soukup, Ph.D.; LF HK

23. OPtimization of Treatment and Management of Schizophrenia in Europe (OpTiMiSE); HEALTH  2009-2.2.1-3; 01/02/2010 - 31/01/2016; CP;  Prof. MUDr. Jan Libiger, CSc.; LF HK

24. Assessing the over the counter medications in primary care and translating the theory of planned behaviour into interventions

(OTC SOCIOMED); FP7-HEALTH-2007-B; 01/12/2009 - 31/05/2012; CP; Prof. RNDr. Jiří Vlček, CSc.; FaF

25. Megacities: emissions, urban, regional and global atmospheric pollution and climate effects, and integrated tools for assessment and mitigation (MEGAPOLI); ENV.2007.; 01/10/2008 - 30/09/2011; CP; Doc. RNDr. Tomáš Halenka, CSc.; MFF

26. Setting up research intensive clusters across the EU on characterization of polymer nanostructures (NAPOLYNET); NMP-2007-2.1-3; 01/04/2008 - 31/03/2011; CSA; RNDr. Lenka Hanyková, Dr.; MFF

27. Clinically oriented translational cancer multilevel modelling (CONTRA CANCRUM); ICT-2007.5.3; 01/08/2008 - 31/07/2011; CP; Doc. RNDr. Zdeněk Hedrlín, CSc.; MFF

28. Nanostructured magnetic materials for nanospintronics (NAMASTE); NMP-2007-2.2-2; 01/09/2008 - 31/08/2011; CP; Prof. RNDr. Václav Holý, CSc.; MFF

29. Quality impact prediction for evolving service-oriented software (Q-IMPRESS); ICT-2007.1.2; 01/01/2008 - 31/12/2010; CP; prof. Ing. František Plášil, DrSc.; MFF

30. Bringing machine translation for european languages to the user (EuroMatrixPlus); FP7-ICT-2007-3; 01/03/2009 - 30/04/2012; CP; Prof. RNDr. Jan Hajič, Dr.; MFF

31. Bringing Machine Translation for European Languages to the User - Enlarged European Union (EuroMatrixPlus-X); FP7-ICT-2009-5; 22 months; Prof. RNDr. Jan Hajič, Dr.; MFF

32. Autonomic Service-Component Ensembles (ASCENS); FP7-ICT-2009-5; 01/10/2010 - 30/09/2014; CP; prof. Ing. František Plášil, DrSc.; MFF

33. Autonomic Service-Component Ensembles - Enlarged EU (ASCENS-EnlargedEU); FP7-ICT-2011-7; doc. Ing. Petr Tůma;; MFF

34. Knowledge Helper for Medical and Other Information users (KHRESMOI); FP7-ICT-2009-5; 01/09/2010 - 31/08/2014; CP; Prof. RNDr. Jan Hajič, Dr.; MFF

35. Analysis for User adaptive Statistical Translation (FAUST); FP7-ICT-2009-4; 01/02/2010 - 31/1/2013; CP; Prof. RNDr. Jan Hajič, Dr.; MFF

36. Technologies for the Multilingual European Information Society (T4ME Net); FP7-ICT-2009-4; 01/01/2010 - 31/01/2013; NOE; Prof. RNDr. Jan Hajič, Dr.; MFF

37. Silicon Nanodots for Solar Cell Tandem (NASCEnT); FP7-NMP-2009-SMALL-3; 01/09/2010 - 31/08/2013; CP; Doc. RNDr. Jan Valenta; MFF

38. Moses Open Source Evaluation and Support Co-ordination for OutReach and Exploitation (MosesCore); FP7-ICT-2011-7; 01/02/2012 - 31/01/2015; CSA; RNDr. Ondřej Bojar, Ph.D.; MFF

39. Biology and control of vector-borne infections in Europe (EDENext); FP7-HEALTH-2010-single-stage; 01/01/2011 - 31/12/2014; CP; Prof. RNDr. Petr Volf, CSc.; PřF

40. Separation and catalytic applications of MOFs (MACADEMIA); FP7-NMP-2008-2.4-1; 01/07/2009 - 30/06/2013; CP; Prof. Petr Nachtigall; PřF

41. GEO Network for Capacity Building (GEONetCab); FP7-ENV-2009-1; 01/11/2009 - 31/10/2012; CSA; Mgr.Přemysl Štych; PřF

42. Evaluating the impact of structural policies on health inequalities and their social determinants and fostering change (SOPHIE); FP7-HEALTH-2011-two-stage; 01/11/2011 - 31/10/2015; CP Doc. Dagmar Dzúrová; PřF

43. Optimal Control Technologies in Quantum Information Processing (QUAINT); FP7-ICT-2011-C; 01/08/2012 - 31/07/2015; RNDr. Zdeněk Tošner, Ph.D; PřF

44. Identifying the needs of medical first responder in disasters (NMFRDISASTER); SEC-2007-7.0-02; 01/05/2008 - 30/06/2009; CSA; PhDr. Štěpán Vymětal; FF

45. Effective Environmental Strategies for the Prevention of Alcohol Abuse among Adolescents in Europe (AAA-PREVENT); FP7-HEALTH-2009-single-stage; 01/01/2010 - 31/12/2012; CP; Doc. PhDr. Jiří Buriánek,CSc.; FF

46. IMProving ACcess to Text (IMPACT); FP7-ICT-2007-1; 01/01/2008 - 31/12/2011 (UK se zapojila až od 04/2010); CP; prof. Karel Kučera; FF - Ústav Českého národního korpusu

47. Implementing the European Space Policy: A Coherent European Procurement Law and Policy for the Space Sector - Towards a Third Way (SP4ESP); FP7-SPACE-2009-1; 01/08/2009 - 31/10/2010; CSA; JUDr. Mahulena Hofmannová; PF

48. A new agenda for European security economics (EUSECON); SEC-2007-6.4-0; 01/03/2008 - 29/02/2012; CP; PhDr. Libor Stejskal; FSV (CESES)

49. Multilateralism and the EU in Contemporary Global Order (MERCURY); FP7-SSH-2007-1; 01/08/2009 - 31/01/2012; CP; Prof. Lenka Rovná, CSc.; FSV

50. Redefining the transatlantic relationship and its role in shaping global governance (TRANSWORD); FP7-SSH-2011-2; 01/03/2012 - 31/082015; CP; Prof. Lenka Rovná, CSc; FSV

51. Combating social exclusion among young homeless populations (CSEYHP); SSH-2007-3.2-01; 01/05/2008 - 30/04/2011; CP; Mgr. Selma Muhič Dizdarevic; FHS

52. INtegrating MainSTREAM Economic Indicators with those of Sustainable Development (IN-STREAM); ENV.2007.; 01/10/2008 - 30/09/2011; CP; Mgr. Milan Ščasný, PhD.; COŽP

53. Full costs of climate change (CLIMATECOST); ENV.2007.; 01/12/2008 - 31/07/2011; CP; Mgr. Milan Ščasný, PhD.; COŽP

54. The Development of Indicators & Assessment Tools for CSO Values-based projects in Education for Sustainable Development (ESDinds); FP7-ENV-2007-1; 20/01/2009 - 19/04/2011; Dr. Tomáš Hák; COŽP

55. PAradigm SHifts Modelling and INnovative Approaches (PASHMINA); FP7-SSH-2009-A; 01/11/2009 - 31/10/2012; CP; Mgr. Milan Ščasný, PhD.; COŽP

56. Increasing the impact of Central-Eastern European environment research results through more effective dissemination and exploitation (ENVIMPACT); FP7-ENV-2010; 01/01/2011 - 30/06/2013; CSA; Mgr. Milan Ščasný, PhD.; COŽP

57. Public health impacts in URban environments of Greenhouse gas Emissions reduction strategies (PURGE); FP7-ENV-2010; 01/02/2011 - 31/07/2014; CP; Mgr. Milan Ščasný, PhD.; COŽP

58. Impacts Quantification of global changes (Global-IQ); FP7-SSH-2010-2; 01/08/2011 - 31/07/2014; CP; Mgr. Milan Ščasný, PhD.; COŽP

59. BRinging Alternative INdicators into POLicy (BrainPool); FP7-ENV-2011; 01/10/2011 - 31/03/2014; CP; Dr. Tomáš Hák; COŽP

60. Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal, and Ecological Scales (SCALES); FP7-ENV-2008-1; 01/05/2009 - 31/07/2014; CP; Doc. David Štorch PhD.; CTS

61. Choosing Efficient Combinations of Policy Instruments for Low-carbon development and Innovation to Achieve Europe's 2050 climate targets (CECILIA2050); FP7-ENV-2012-one-stage; 01/09/2012 - 31/08/2015; Mgr. Milan Ščasný, PhD.; COŽP

62. Design of Thin-Film Nanocatalysts for On-Chip Fuel Cell Technology (chipCAT); FP7-NMP-2012-SMALL-6; 01/12/2012 - 30/11/2016; prof. RNDr. Vladimír Matolín, DrSc.; MFF (koordinátor)

63. Making Persons with Disabilities Full Citizen (DISCIT); FP7-SSH-2012-2; 01/01/2013 - 31/12/2015; doc. Jan Šiška; PedF

64. Teaching Enquiry with Mysteries Incorporated (TEMI); FP7-SCIENCE-IN-SOCIETY-2012-1; 01/01/2013 - 31/07/2016; prof. RNDr. Hana Čtrnáctová, CSc.; PřF

65. Smart Specialisation For Regional Innovation (SmartSpec); FP7-SSH-2012-2; 01/07/2013 - 30/06/2016; doc. RNDr. Jiří Blažek, Ph.D.; PřF

66. Economics of climate change adaptation in Europe (ECONADAPT); FP7-ENV-2013-two-stage; 1/10/2013-30/9/2016; Milan Ščasný; COŽP

67. CAScade deoxygenation process using tailored nanoCATalysts for the production of BiofuELs from lignocellullosic biomass (CASCATBEL); FP7-NMP-2013-LARGE-7; 01/11/2013 - 31/10/2017; Prof. Petr Nachtigall; PřF

68. Earth Observation for Economic Empowerment (EOPOWER); FP7-ENV-2013-one-stage; 01/06/2013 - 31/05/2015; RNDr. Přemysl Štych, Ph.D.; PřF

69. Clonidine for Sedation of Paediatric Patients in the Paediatric Intensive Care Unit (CloSed); FP7-HEALTH-2013-INNOVATION-1; 01/12/2013 - 30/11/2018; MUDr. Pavla Pokorná; 1.LF

Poslední změna: 12. listopad 2014 16:07 
Sdílet na:  
Váš názor

Univerzita Karlova

Ovocný trh 560/5

Praha 1, 116 36

Česká republika

Identifikátor datové schránky: piyj9b4

IČO: 00216208 

DIČ: CZ00216208

Jak k nám